DK2856152T3 - Nye biomarkører til at skønne risikoen for allotransplantationssvigt og patientdødelighed efter organtransplantation - Google Patents
Nye biomarkører til at skønne risikoen for allotransplantationssvigt og patientdødelighed efter organtransplantation Download PDFInfo
- Publication number
- DK2856152T3 DK2856152T3 DK13729629.9T DK13729629T DK2856152T3 DK 2856152 T3 DK2856152 T3 DK 2856152T3 DK 13729629 T DK13729629 T DK 13729629T DK 2856152 T3 DK2856152 T3 DK 2856152T3
- Authority
- DK
- Denmark
- Prior art keywords
- assess
- risk
- organ transplantation
- new biomarkers
- patient mortality
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material
- G01N2440/10—Post-translational modifications [PTMs] in chemical analysis of biological material acylation, e.g. acetylation, formylation, lipoylation, myristoylation, palmitoylation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Transplantation (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12170756.6A EP2671574A1 (en) | 2012-06-04 | 2012-06-04 | Use of vitamin K to decrease allograft failure and patient mortality after organ transplantation |
PCT/EP2013/061519 WO2013182579A1 (en) | 2012-06-04 | 2013-06-04 | New biomarkers to estimate the risk of allograft failure and patient mortality after organ transplantation |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2856152T3 true DK2856152T3 (da) | 2021-11-01 |
Family
ID=48651994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK13729629.9T DK2856152T3 (da) | 2012-06-04 | 2013-06-04 | Nye biomarkører til at skønne risikoen for allotransplantationssvigt og patientdødelighed efter organtransplantation |
Country Status (11)
Country | Link |
---|---|
US (2) | US20150153352A1 (da) |
EP (3) | EP2671574A1 (da) |
DK (1) | DK2856152T3 (da) |
ES (1) | ES2891249T3 (da) |
HR (1) | HRP20211676T1 (da) |
HU (1) | HUE056601T2 (da) |
LT (1) | LT2856152T (da) |
PL (1) | PL2856152T3 (da) |
PT (1) | PT2856152T (da) |
SI (1) | SI2856152T1 (da) |
WO (2) | WO2013182579A1 (da) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180199610A1 (en) * | 2015-02-20 | 2018-07-19 | Vitak B.V. | Vitamin k and capillary function |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5635478A (en) * | 1989-09-18 | 1997-06-03 | Yale University | Use of calcitonin gene-related peptide to regulate immune response |
WO2000008495A2 (en) * | 1998-08-06 | 2000-02-17 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Antiproliferative naphthoquinones, derivatives, compositions, and uses thereof |
US7700296B2 (en) | 1999-07-04 | 2010-04-20 | Mgp Diagnostics As | Diagnostic assay for human Matrix Gla-protein and its use as a biomarker |
ES2296634T3 (es) | 1999-07-04 | 2008-05-01 | Cardiovascular Research Institute Of Maastricht (Carim) | Ensayo de diagnostico para proteina gla de matriz humana y su utilizacion como biomarcador. |
PT1153548E (pt) | 2000-05-12 | 2007-08-08 | Nattopharma Asa | Produto alimentar contendo vitamina k |
AU2003304180A1 (en) * | 2002-09-24 | 2005-01-04 | Dow, Kenneth, Centocor, Inc. | Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses |
US20070111210A1 (en) * | 2003-12-03 | 2007-05-17 | Marc Bigaud | Biomarkers for graft rejection |
WO2005107731A1 (ja) * | 2004-05-12 | 2005-11-17 | Eisai R & D Management Co., Ltd. | ビタミンk2を有効成分として含む治療剤 |
RU2318500C2 (ru) * | 2005-10-18 | 2008-03-10 | Общество С Ограниченной Ответственностью "Митотехнология" | Способ воздействия на организм путем адресной доставки биологически активных веществ в митохондрии, фармацевтическая композиция для его осуществления и соединение, применяемое для этой цели |
WO2008147283A1 (en) * | 2007-05-25 | 2008-12-04 | Leif Salford | The use of zeburaline for the treatment of autoimmune diseases or immune rejection of transplants |
CA2805745C (en) * | 2010-07-19 | 2019-01-15 | Summa Health System | Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease |
-
2012
- 2012-06-04 EP EP12170756.6A patent/EP2671574A1/en not_active Withdrawn
-
2013
- 2013-06-04 US US14/405,107 patent/US20150153352A1/en not_active Abandoned
- 2013-06-04 DK DK13729629.9T patent/DK2856152T3/da active
- 2013-06-04 US US14/405,106 patent/US20150141386A1/en not_active Abandoned
- 2013-06-04 ES ES13729629T patent/ES2891249T3/es active Active
- 2013-06-04 PL PL13729629T patent/PL2856152T3/pl unknown
- 2013-06-04 PT PT137296299T patent/PT2856152T/pt unknown
- 2013-06-04 WO PCT/EP2013/061519 patent/WO2013182579A1/en active Application Filing
- 2013-06-04 EP EP13729629.9A patent/EP2856152B1/en active Active
- 2013-06-04 SI SI201331932T patent/SI2856152T1/sl unknown
- 2013-06-04 LT LTEPPCT/EP2013/061519T patent/LT2856152T/lt unknown
- 2013-06-04 EP EP13729628.1A patent/EP2854788A1/en active Pending
- 2013-06-04 HR HRP20211676TT patent/HRP20211676T1/hr unknown
- 2013-06-04 HU HUE13729629A patent/HUE056601T2/hu unknown
- 2013-06-04 WO PCT/EP2013/061518 patent/WO2013182578A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
PT2856152T (pt) | 2021-09-29 |
SI2856152T1 (sl) | 2022-01-31 |
WO2013182578A1 (en) | 2013-12-12 |
US20150153352A1 (en) | 2015-06-04 |
US20150141386A1 (en) | 2015-05-21 |
WO2013182579A1 (en) | 2013-12-12 |
LT2856152T (lt) | 2021-12-10 |
EP2856152B1 (en) | 2021-08-04 |
PL2856152T3 (pl) | 2022-02-07 |
ES2891249T3 (es) | 2022-01-26 |
EP2854788A1 (en) | 2015-04-08 |
HRP20211676T1 (hr) | 2022-02-18 |
EP2856152A1 (en) | 2015-04-08 |
EP2671574A1 (en) | 2013-12-11 |
HUE056601T2 (hu) | 2022-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3545906T3 (da) | Indretning til udskiftning af hjerteklap | |
DK2970951T3 (da) | Fremgangsmåder til nukleinsyresekventering | |
DK2875743T3 (da) | Kittel | |
DK3351239T3 (da) | Prostamid-indeholdende intraokulære implantater og fremgangsmåder til anvendelse deraf | |
DK3071222T3 (da) | Celle | |
FI20135520A (fi) | Kannettava sykemittari | |
DK2838533T3 (da) | Sammensætninger og fremgangsmåder til at modulere 15-pgdh-aktivitet | |
BR112014027348A2 (pt) | compostos agonistas duplos gip-glp-1 e métodos | |
DK2730215T3 (da) | Dynamisk urinmonitor | |
DK3158975T3 (da) | Protesesystem til hjerteklaperstatning | |
DK2664816T3 (da) | Teleskoperende stræber | |
DK3050883T3 (da) | Fremgangsmåde til fremstilling af diazabicyclooctanderivater og mellemprodukter | |
DK3044315T3 (da) | Nukleinsyrer og fremgangsmåder til behandling af pompes sygdom | |
FI20126266A (fi) | Pehmopaperin mittaus | |
DK2715352T3 (da) | Fremgangsmåde til vurdering af risiko for pml | |
DK3326642T3 (da) | Langtidsvirkende koagulationsfaktorer og brugen deraf | |
DK2964767T3 (da) | Toksingener og fremgangsmåder til anvendelse deraf | |
DK2992104T3 (da) | Fremgangsmåde til ekspression | |
CL2016001220A1 (es) | Gasa quirurgica | |
BR112014025931A2 (pt) | método para fabricar células-tronco tendo tamanho apropriado para administração intravascular | |
DK2970432T3 (da) | Ex vivo human multipel myelomcancer-niche og anvendelse deraf som model til multipelt myelom | |
DK2988659T3 (da) | Forbedrede fremgangsmåder til vævskarakterisering | |
DK3150710T3 (da) | Fremgangsmåde til fremstilling af homoserin-lacton og organisk syre fra mikroorganisme-afledt o-acyl-homoserin | |
DK3111492T3 (da) | Elektrokemisk energilager og fremgangsmåde til drift deraf | |
FI20135231A (fi) | Potilasalusta |